Global Infectious Diseases and One Health Conference
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Global Infectious Diseases and One Health Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
Global Infectious Diseases & One Health Conference (GIOH 2026)
The Global Infectious Diseases & One Health Conference (GIOH 2026) is a hybrid conference scheduled for September 21–23, 2026 in London, United Kingdom, with participation available in person and online. The event brings together a global community focused on infectious disease prevention, treatment, control, and preparedness, under the theme “From Breakthroughs to Preparedness: The Next Era of Infectious Diseases.”
Why this conference matters
GIOH 2026 is positioned as a landmark gathering for the infectious disease community, designed to support knowledge exchange across multiple disciplines and decision-making levels. It serves as a platform where thought leaders, researchers, healthcare practitioners, and policymakers collaborate to address critical challenges in how the world detects emerging threats, responds to outbreaks, and builds resilience for the future.
Core themes and conference focus
Across multiple sessions, the conference emphasizes the full lifecycle of infectious disease response—from early detection to clinical intervention and infection control—while also addressing the interconnected nature of human, animal, and environmental health through the One Health Approach. The program includes focused coverage of issues such as:
- Emerging Infectious Diseases & Outbreak Preparedness: learning from recent outbreaks, strengthening early detection, and improving coordinated response strategies.
- One Health: exploring how integrated human, animal, and environmental approaches can help combat zoonotic diseases and shared health threats.
- Detection, Diagnosis, and Clinical Response: practical insights into how diagnostics, treatment strategies, and clinical management support better outcomes.
- Infection Control and Prevention: strategies to reduce transmission and strengthen prevention measures across healthcare and community settings.
- Advances in biology and therapeutics: including molecular biology, genomics, microbiology, immunology, novel therapeutics, and drug development pathways.
- R&D and Clinical Trials: representing ongoing scientific progress and evidence generation that supports translational advances.
Conference format and participation
This event is a Hybrid Event, meaning it supports engagement both on-site and remotely. The official venue location is listed as London, United Kingdom, with online attendance available. This structure enables global participation from stakeholders who focus on infectious diseases and One Health topics.
Conference date and venue details
Dates: September 21–23, 2026
Venue: London, United Kingdom and Online
Event type: Hybrid Conference
Abstract and registration timelines (as published)
The conference website indicates the following timeframes:
- Early Registration closes: July 15, 2026
- Second Phase of Abstract Submission closes: July 14, 2026
CPD accreditation
The conference is described as a CPD Accredited Event, offering participants the opportunity to earn 15+ CPD credits by staying current with the latest advances in the field.
Highlighted subject areas (official abstract topics)
The conference outlines multiple abstract topic categories, including:
- Infectious Diseases
- Detection and Diagnosis
- Clinical Management and Treatment Strategies
- Infection Control and Prevention
- Molecular Biology and Genomics
- Microbiology and Immunology
- Novel Therapeutics and Drug Development
- R&D and Clinical Trials
Overall, GIOH 2026 offers a structured forum for cross-disciplinary collaboration on infectious disease innovation, preparedness planning, and One Health-aligned strategies—bringing together international expertise to support improved outcomes in prevention, detection, and response worldwide.
Data sheet
Global Infectious Diseases and One Health Conference – Event Attendee & Buyer Profile Analysis
Event Date: September 21-23, 2026
Location: London, United Kingdom and Online
Event Status: Upcoming
Research Date: July 1, 2026
Event Overview
| Event Name | Global Infectious Diseases & One Health Conference |
| Event Date | September 21-23, 2026 |
| Event Status | Upcoming |
| Venue | London, United Kingdom and Online |
| City | London |
| State / Region | Greater London / England |
| Country | United Kingdom |
| Organizer | Miconferences / Infection Conference (official site branding) |
| Official Event Website | infection.miconferences.com |
| Event Type | Hybrid scientific conference / educational summit / research and public health networking event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Education & Training |
| Audience Reach | Global, with in-person participation in London and online access |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for total attendance; high for event dates, format, and topic confirmation from the official website. |
| Main Purpose of Event | To bring together infectious disease researchers, healthcare practitioners, policymakers, and related stakeholders to discuss diagnostics, therapeutics, outbreak preparedness, infection control, genomics, and the One Health approach. |
About the Event
The Global Infectious Diseases & One Health Conference 2026 is a hybrid, research-oriented conference focused on the prevention, diagnosis, treatment, and control of infectious diseases. The official program emphasizes emerging infectious diseases, outbreak preparedness, infection control and prevention, molecular biology and genomics, microbiology and immunology, novel therapeutics, and clinical trials.
This event matters because it sits at the intersection of public health, clinical practice, laboratory science, and policy. Its One Health framing broadens the attendee base beyond human health to include the interconnected roles of animal and environmental health, making it relevant for researchers, healthcare systems, diagnostics and therapeutics suppliers, public sector buyers, and organizations involved in epidemic preparedness and disease surveillance.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Healthcare procurement teams | Hospitals, hospital networks, NHS trusts, clinics, integrated care systems | Evaluate diagnostics, infection-control products, lab services, and clinical solutions | High relevance for diagnostics, PPE, monitoring, laboratory, and infection prevention suppliers |
| Public health and government buyers | Health agencies, ministries, national public health bodies, local health authorities | Specify surveillance, preparedness, testing, and outbreak-response tools | Important for vendors serving government health programs and national preparedness initiatives |
| Clinical researchers / principal investigators | Universities, medical schools, research institutes, teaching hospitals | Influence trial design, assay selection, lab partnerships, and funded research procurement | Strong fit for assay, reagent, sequencing, and trial-support suppliers |
| Laboratory directors and lab managers | Clinical labs, reference labs, academic labs, pathology services | Purchase instrumentation, consumables, testing workflows, and biosafety solutions | High-value audience for lab automation, diagnostics, and quality-control providers |
| Infection prevention and control leaders | Hospitals, long-term care providers, public health systems | Influence product standards for disinfection, isolation, and containment | Strong audience for sanitation, surveillance, and compliance suppliers |
| Pharma and biotech R&D teams | Drug developers, vaccine developers, biotech firms | Seek trial collaborations, biomarker research, and clinical evidence partnerships | Relevant for CROs, CDMOs, trial services, and translational research vendors |
| One Health and zoonotic disease stakeholders | Veterinary research bodies, animal health institutes, environmental health organizations | Influence cross-sector surveillance, research, and prevention programs | Relevant for cross-sector health technology, lab, and data platforms |
| Policy and program leaders | Public sector agencies, NGOs, global health bodies, foundations | Set priorities, fund pilots, commission studies, and approve procurement pathways | Relevant for government-facing vendors and service providers |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: London | Local and metro-area healthcare, research, and policy professionals | High | London offers access to major NHS, academic, and life-science stakeholders |
| Host state / region: England | Delegates from England-wide institutions and health networks | High | Strong domestic draw for clinical and public health audiences |
| Nearby business hubs | Oxford, Cambridge, Reading, Birmingham, Manchester, Bristol | Medium to High | Likely attendance from research, hospital, and biotech corridors |
| National reach | UK-wide attendees from healthcare, universities, labs, and government | High | The event theme aligns with nationwide public health and scientific priorities |
| International reach | Europe, North America, Asia-Pacific, Middle East, Africa, global public health institutions | High | The official website describes a global gathering and hybrid access broadens participation |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official description positions the event as a worldwide forum with hybrid access and an international speaker profile. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| NHS England | Government / healthcare system buyer | Major public healthcare buyer for infection prevention, diagnostics, and preparedness solutions | england.nhs.uk | Procurement Director, Head of Infection Prevention, Clinical Lead, Category Manager | Strong Market Fit, Attendance Not Confirmed |
| UK Health Security Agency | Government / public health buyer | Relevant for surveillance, outbreak response, diagnostics, and epidemiology tools | gov.uk/government/organisations/uk-health-security-agency | Programme Manager, Scientific Director, Procurement Lead, Data/Surveillance Lead | Strong Market Fit, Attendance Not Confirmed |
| World Health Organization | Global public health buyer / policy body | Aligned with global infectious disease preparedness, guidance, and One Health priorities | who.int | Technical Officer, Procurement Officer, Programme Manager, Public Health Specialist | Strong Market Fit, Attendance Not Confirmed |
| Centers for Disease Control and Prevention | Government / public health buyer | Potential stakeholder for diagnostics, outbreak response, and surveillance solutions | cdc.gov | Branch Chief, Project Officer, Epidemiologist, Procurement Specialist | Strong Market Fit, Attendance Not Confirmed |
| Imperial College London | Academic / research buyer | Officially represented on the speaker/committee side; strong fit for lab and research solutions | imperial.ac.uk | Principal Investigator, Lab Manager, Research Procurement, Department Administrator | Confirmed Speaker Organization |
| University of Manchester | Academic / research buyer | Confirmed speaker organization; likely interest in infectious disease research tools and partnerships | manchester.ac.uk | Professor, Research Director, Lab Manager, Procurement Officer | Confirmed Speaker Organization |
| Brown University | Academic / research buyer | Speaker organization with strong relevance to biomedical research, microbiology, and translational work | brown.edu | Dean, PI, Lab Director, Research Operations, Procurement Lead | Confirmed Speaker Organization |
| University of Regensburg | Academic / research buyer | Speaker organization and a relevant research institution for diagnostics and infection science | ur.de | Professor, Research Fellow, Lab Head, Scientific Administrator | Confirmed Speaker Organization |
| University of Notre Dame | Academic / research buyer | Speaker organization with research relevance in disease biology and immunology | nd.edu | Faculty Researcher, Lab Manager, Procurement Officer, Grants Manager | Confirmed Speaker Organization |
| National Health Service Trusts | Hospital buyer group | Natural buyers for infection-control, diagnostics, and patient safety solutions | nhs.uk | Category Manager, Procurement Lead, Infection Control Nurse, Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Public Health Agency of Canada | Government / public health buyer | Relevant for infectious disease preparedness, surveillance, and research collaboration | canada.ca/en/public-health | Program Manager, Scientist, Procurement Analyst, Epidemiologist | Strong Market Fit, Attendance Not Confirmed |
| National Institute for Communicable Diseases | Government / public health buyer | Strong fit for diagnostics, epidemiology, and outbreak surveillance vendors | nicd.ac.za | Director, Epidemiologist, Lab Head, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Veterinary Laboratories Agency | Government / veterinary research buyer | Relevant to One Health, zoonotic disease surveillance, and cross-species diagnostics | gov.uk/government/organisations/veterinary-laboratories-agency | Scientific Lead, Lab Manager, Procurement Officer, Program Director | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Chief Scientific Officer | Executive Leadership | C-level | Sets research, clinical, and innovation priorities for infectious disease solutions |
| 2 | Director of Procurement / Category Manager | Procurement / Supply Chain | Director / Manager | Purchases diagnostics, lab equipment, and infection-control supplies |
| 3 | Laboratory Director / Lab Manager | Laboratory / Operations | Director / Manager | Controls testing workflows, instrumentation choices, and consumable purchasing |
| 4 | Infection Prevention and Control Lead | Clinical Quality / Patient Safety | Lead / Manager | Evaluates containment, hygiene, and prevention systems |
| 5 | Epidemiologist / Surveillance Lead | Public Health / Analytics | Senior Specialist / Manager | Influences outbreak modeling, detection platforms, and data tools |
| 6 | Principal Investigator / Professor | Research / Academic Affairs | Senior / Faculty | Influences grant-funded purchases and scientific collaborations |
| 7 | Program Manager / Project Manager | Program Delivery / Public Health | Manager | Coordinates pilots, research programs, and external vendors |
| 8 | Director of Clinical Research / Trial Operations | Clinical Development | Director | Relevant for therapeutics, biomarkers, and clinical trial service providers |
| 9 | Head of Microbiology / Immunology | Scientific / Laboratory | Head / Director | Key influencer for assays, reagents, and research partnerships |
| 10 | One Health / Veterinary Health Lead | Cross-Sector Health | Lead / Director | Important for zoonotic disease, surveillance, and cross-sector initiatives |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Primary end-user base for infection control and diagnostics | Hospitals, trusts, clinics, ICUs, infection prevention teams |
| 2 | Pharmaceuticals | Therapeutics, vaccines, trial collaboration, antimicrobial R&D | Clinical development, research, medical affairs |
| 3 | Biotechnology | Diagnostics, biomarker, genomics, and translational science relevance | R&D leaders, lab services, assay providers |
| 4 | Government Administration | Public health agencies and ministries are central to preparedness | Policy, surveillance, procurement, response programs |
| 5 | Research | The event is research-heavy and academically oriented | Universities, institutes, PI-driven buying |
| 6 | Medical Devices | Testing, monitoring, sampling, and clinical workflow tools | Diagnostic hardware and clinical equipment buyers |
| 7 | Public Policy | Policy design and public health governance are relevant | Government decision-makers and advisors |
| 8 | Environmental Services | One Health and environmental reservoirs matter in disease spread | Cross-sector monitoring and environmental testing |
| 9 | Veterinary | One Health focus includes animal health and zoonoses | Veterinary labs, zoonotic surveillance, animal-health R&D |
| 10 | Information Technology & Services | Data platforms, surveillance systems, and analytics support outbreak response | Health data, workflow, and interoperability solutions |
| 11 | Environmental Services | Infection spread is connected to environment and sanitation controls | Decontamination and sanitation providers |
| 12 | Education Management | Universities and training institutions are core attendee groups | Academic partnerships, continuing education tools |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unconfirmed | Official website does not publish an attendance number | Attendance figure not publicly confirmed by the organizer. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor directory shown on the provided official text | Scientific conference format may be sponsor-light or exhibit-light |
| Buyer count | Not publicly confirmed | Unconfirmed | No attendee breakdown published | Likely mix of researchers, clinicians, and policy stakeholders |
| Speaker count | At least 4 named speakers/committee members visible in the provided text | Confirmed partial data | Official website excerpt | Full speaker roster not fully visible in the supplied content |
| Sponsor count | Not publicly confirmed | Unconfirmed | No sponsor list visible in supplied official text | Potential journal collaborations are referenced, but sponsor roster is not confirmed |
| Historical attendance | Not available in supplied official text | Unavailable | No prior-year attendance figure provided | Use attendee profiling rather than volume assumptions |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Diagnostics | Rapid and accurate detection tools | Demonstrate sensitivity, turnaround time, and workflow fit | Assays, analyzers, sample prep, lab automation |
| Therapeutics | Treatment development and clinical evidence | Discuss trial support, patient stratification, and translational data | Biopharma services, CRO, biomarkers, real-world evidence |
| Outbreak preparedness | Readiness, response, and contingency planning | Position solutions for agencies and hospitals planning for future events | Surveillance platforms, planning software, emergency response tools |
| Infection control | Reduce transmission and maintain compliance | Show measurable reductions in risk and operational burden | Disinfection, PPE, filtration, biosafety supplies |
| Genomics / molecular biology | Pathogen characterization and tracking | Link sequencing capabilities to surveillance and research outputs | Sequencing platforms, reagents, bioinformatics |
| One Health / zoonotic disease | Cross-species and environmental disease risk understanding | Engage veterinary, environmental, and public health stakeholders together | Integrated surveillance, field testing, environmental monitoring |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The audience is closely aligned with healthcare, public health, lab science, and research buying needs. |
| Decision-maker availability | High | Likely to include directors, heads of department, principal investigators, and policy leaders. |
| Data collection potential | Medium | Current attendee and buyer lists are not publicly confirmed in the supplied content. |
| Apollo targeting potential | Very High | Clear fit for healthcare, research, government, biotech, and laboratory buyer filters. |
| Geographic targeting potential | High | Strong UK, Europe, and global public health targeting opportunity. |
| Best outreach approach | High-touch, research-led | Use agenda-driven messaging, role-based personalization, and scientific relevance. |
| Overall lead quality | High | Strong event for building B2B lists in health, research, and public-sector segments. |
| Best use case | Prospecting, attendee list building, and public-health account mapping | Best suited for suppliers to labs, hospitals, agencies, and research organizations. |
| Limitations / risks | Incomplete attendance visibility | No confirmed public attendee roster or footfall figure in the supplied official content. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Government Administration; Research; Medical Devices; Information Technology & Services; Veterinary; Public Policy; Environmental Services | Capture the core buyer ecosystem around infectious diseases and One Health |
| Departments | Procurement; Supply Chain; Clinical Affairs; Research; Public Health; Laboratory; Operations; Innovation; Medical Affairs; Program Management | Reach both budget owners and technical evaluators |
| Seniority | C-level; VP; Director; Head; Manager; Senior Manager; Principal; Lead | Prioritize decision-makers and department heads |
| Job titles | Chief Medical Officer, Chief Scientific Officer, Director of Procurement, Procurement Manager, Head of Infection Prevention, Lab Director, Epidemiologist, Program Manager, Principal Investigator, Director of Clinical Research | Target the most likely budget influencers and technical buyers |
| Geography | United Kingdom; Ireland; Europe; North America; selected APAC and Middle East public health hubs | Match the event’s global reach and London draw |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001-10,000; 10,000+ | Cover research institutions, hospitals, and government bodies |
| Keywords | infectious disease, outbreak preparedness, infection prevention, One Health, diagnostics, public health, epidemiology, laboratory, genomics, clinical trials | Improve relevance scoring for event-based outreach |
| Company type | Public sector, academic, hospital network, biotech, pharma, diagnostic lab, veterinary health, NGO | Align to attendee mix and procurement behavior |
| Technologies | LIMS, EMR/EHR, lab automation, genomics platforms, surveillance dashboards, clinical trial software | Useful for software and digital health sellers |
| Revenue range | Not essential; prioritize institution type and department first | Revenue filters may exclude public and academic targets |
Suggested Apollo Search Logic: Combine industry, department, and title filters with keywords such as infectious disease, outbreak preparedness, One Health, infection prevention, diagnostics, epidemiology, and laboratory. Example logic: (Hospital & Health Care OR Government Administration OR Biotechnology OR Pharmaceuticals) AND (procurement OR research OR public health OR laboratory) AND (director OR head OR manager OR chief).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Infection Conference official website | Primary source / organizer website | Event name, dates, hybrid format, London/UK location, topic areas, CPD note, committee and speaker names shown in provided content | High |
| About Conference page | Official event page | Conference positioning, One Health theme, audience framing, and session themes | High |
| Scientific Program page | Official agenda page | Likely topic focus areas such as diagnostics, therapeutics, AMR, and outbreak preparedness | High |
| Speakers page | Official speaker page | Named speaker organizations and academic participation evidence visible in supplied text | High |
| General Information page | Official event information page | Registration timing and event logistics referenced in the official content | Medium to High |
| About Organizer page | Official organizer page | Organizer identity and event-series context, where available | Medium to High |
| NHS | Government / healthcare system reference | Buyer-side organization reference for healthcare procurement relevance | High |
| UK Health Security Agency | Government agency reference | Potential public-sector buyer profile for infectious disease and surveillance solutions | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Global Infectious Diseases and One Health Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds